GlassScriptPhysician profile
Andrew B Morris
NPI 1245492602
$5,512.34
in general payments reported to CMS, 2019-2025
43 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,773 · 2020: $359 · 2021: $329 · 2022: $1,147 · 2023: $1,051 · 2024: $522 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,458.87 | 2019-2020 | |
| Abbvie INC. | $577.32 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $512.59 | 2019-2024 | Xiaflex |
| Antares Pharma, INC. | $299.85 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Axonics, INC. | $233.95 | 2022-2024 | Bulkamid, Axonics |
| Astellas Pharma US INC | $214.56 | 2019-2023 | Myrbetriq |
| Urovant Sciences INC | $179.98 | 2021-2022 | |
| Janssen Biotech, INC. | $155.08 | 2019-2022 | |
| Boston Scientific Corporation | $132.43 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml |
| Medtronic, INC. | $125.43 | 2022 | |
| Progenics Pharmaceuticals, INC. | $115.59 | 2022-2024 | Pylarify |
| C. R. Bard, INC. & Subsidiaries | $110.66 | 2019-2023 | Bard Urinary Drainage Bag |
| Kowa Pharmaceuticals America, INC. | $109.97 | 2022-2023 | Seglentis |
| Sumitomo Pharma America, INC. | $109.05 | 2023-2025 | Gemtesa, Orgovyx |
| Endo USA, INC. | $107.25 | 2024-2025 | Xiaflex |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $105.00 | 2023 | Dupixent |
| Pfizer INC. | $81.26 | 2022-2023 | |
| Olympus America INC. | $79.88 | 2022-2025 | Itind System |
| Blue Earth Diagnostics | $67.04 | 2019-2022 | |
| Convatec INC. | $60.35 | 2021-2022 | |
| Tolmar, INC. | $58.12 | 2024-2025 | Eligard, Jatenzo |
| Procept Biorobotics Corporation | $53.09 | 2024-2025 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $52.77 | 2020-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $49.33 | 2021 | |
| Travere Therapeutics, INC. | $45.66 | 2020-2022 | |
| Urogen Pharma, INC. | $42.59 | 2021-2025 | |
| 180 Medical, INC. | $39.07 | 2019-2020 | |
| Teleflex LLC | $34.74 | 2023-2024 | Urolift |
| Allergan, INC. | $26.77 | 2020 | |
| Becton, Dickinson and Company | $25.87 | 2024 | Bard Urinary Drainage Bag |
| Genzyme Corporation | $24.14 | 2022 | |
| Cook Medical LLC | $23.68 | 2024 | Resonance |
| Halozyme INC | $23.06 | 2023 | |
| Integra Lifesciences Corporation | $22.67 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Alnylam Pharmaceuticals INC. | $22.15 | 2023 | Oxlumo |
| Telix Pharmaceuticals | $22.00 | 2023 | Illuccix |
| Foundation Medicine, INC. | $19.91 | 2022 | |
| Ethicon US, LLC | $17.49 | 2019 | |
| Galvanize Therapeutics, INC | $16.03 | 2025 | Aliya System |
| Calyxo, INC. | $15.06 | 2024 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $14.82 | 2021 | |
| Clarus Therapeutics INC. | $14.42 | 2021 | |
| Karl Storz Endoscopy-America | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.